Seeking Alpha EN

Stereotaxis GAAP EPS of -$0.06 beats by $0.01, revenue of $8.64M misses by $0.6M

Mar 09, 2026 &03050909202631; 20:05 UTC seekingalpha.com Trending 2/5

Read original on seekingalpha.com ↗

↘

Negative for markets

Sentiment score: -35/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Stereotaxis reported GAAP EPS of -$0.06, beating expectations by $0.01, but revenue of $8.64M fell short of consensus by $0.6M. The mixed earnings result shows operational challenges despite marginal EPS outperformance.

AI CONFIDENCE

72% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

STXS

STXSStock

Expected to decline

Revenue miss of 6.5% is more significant than EPS beat; continued losses indicate profitability challenges in medical device sector

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Consider avoiding or reducing positions in STXS; the revenue miss outweighs the marginal EPS beat. Monitor upcoming guidance and cash burn rate for signs of operational improvement or potential dilution.

KEY SIGNALS

Revenue miss indicates weak demand or market penetration issuesNegative EPS shows company remains unprofitableEPS beat offset by larger revenue disappointmentMedical device sector facing headwinds

SECTORS INVOLVED

HealthcareMedical DevicesBiotechnology

Analysis generated on Mar 10, 2026 at 00:30 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Stereotaxis GAAP EPS of -$0.06 beats by $0.01, revenue of $8.64M misses by $0.6M

RELATED INTELLIGENCE